Clinical Trial Update: Cabozantinib in Patients With Advanced Hepatocellular Carcinoma With Child Pugh Class B Cirrhosis After First-Line Therapy [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update on cabozantinib for advanced hepatocellular carcinoma with Child-Pugh B cirrhosis after first-line therapy. The study was terminated, and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Cabometyx (cabozantinib)

Snippet

Sponsor: University of Michigan Rogel Cancer Center | Conditions: Advanced Adult Hepatocellular Carcinoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2024-08-06